Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study.

Han Eol JeongSohee ParkYunha NohSungho BeaKristian B FilionOriana H Y YuSeung Hun JangYoung Min ChoDong Keon YonJu Young Shin

Published in: BMC medicine (2023)

These findings suggest a lower risk of adverse respiratory events associated with patients with T2D initiating SGLT2is versus DPP4is. This real-world evidence helps inform patients, clinicians, and guideline writers regarding the respiratory effects of SGLT2i in routine practice.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
primary care
peritoneal dialysis
emergency department
clinical practice
adverse drug